MAGN vs NUS

MAGN exhibits severe financial distress as evidenced by a weak Piotroski F-Score of 2/9, indicating a deteriorating fundamental position. While the stock appears deeply undervalued on a Price-to-Book (0.34) and Price-to-Sales (0.11) basis, these metrics are offset by negative ROE (-12.41%) and a catastrophic 5-year price decline of 94.5%. The company's earnings track record is abysmal, with zero beats in the last four quarters and massive negative surprises. Despite a healthy current ratio, the high debt-to-equity ratio and consistent operational misses suggest a value trap rather than a recovery play.

NUS presents a classic 'value trap' profile, characterized by a weak Piotroski F-Score of 3/9 and a bearish technical trend of 0/100. While the company is trading at a massive discount to its Graham Number ($34.57) and Intrinsic Value ($22.26), this is offset by a severe revenue contraction of -16.90% YoY. The balance sheet remains healthy with low debt (D/E 0.38) and strong liquidity, but the operational decay suggests the market is pricing in a permanent decline in the business model.